openPR Logo
Press release

Cardiology Conference 2022

06-08-2021 11:15 AM CET | Health & Medicine

Press release from: Scientex Conference

Heart Conference 2022

Heart Conference 2022

Theme: "Exploring New Research and Frontiers in Heart Care"

Heart 2022 welcomes all the eminent professional scholars, researchers and beloved students to be a part of this “INTERNATIONAL CONFERENCE ON CLINICAL CARDIOLOGY & CONGENITAL HEART DISEASE” scheduled on FEBRUARY 07-08, 2022 | PARIS | FRANCE. With individuals from around the world zeroed in on finding a few solutions concerning Cardiology, this is your single most clear chance to achieve the best amassing of people from the mending focuses, Universities, Heart Associations, and so forth...

Target Audience:
· Cardiology Students, Scientists
· Cardiology Researchers
· Cardiology Faculty
· Cardiovascular Physicians
· Medical Colleges
· Cardiology Associations and Societies
· Business Entrepreneurs
· Training Institutes
· Software making associations
· Manufacturing Medical Devices Companies
· Data Management
· Medical Engineers
· Heart Care Nutrionist

Scientific Highlights
Heart Disease & Failure
Heart Diagnosis
Cardiac and Cardiovascular Research
Heart Devices
Diabetes, Obesity & Stroke
Interventional Cardiology
Nuclear Cardiology, Molecular Cardiology, Cardio-Oncology
Pediatric Cardiology & Women’s Cardiology
Cardiac Nursing
Heart Regeneration
Cardiac Pharmacology, Cardiac Surgery
Cardiac Diet/Cardiac Nutrition
Cardiovascular Impact of COVID-19
Case Reports on Cardiology
Cardiology - Future Medicine

https://www.heart.scientexconference.com/
heart@scientexevents.com

Paris

Examining the best spot to exchange your ideas on Heart??? Here the Scientex conference provides an excellent global platform for professionals in cardiovascular health by organizing conferences, workshops, seminars, B2B sessions in addition to interactive gathering from all over the world with the wide range of discussing innovational discoveries to advance the aegis and medicaments of heart and vascular conditions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiology Conference 2022 here

News-ID: 2299312 • Views: 874

More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an